ISCADOR P Series I Solution for Injection, 14X1 ml

Instructions for use for ISCADOR P Series I Solution for Injection, 14X1 ml

Directions for use of the article ISCADOR P SERIE I Iscador P is an anthroposophical medicinal product used for the extended treatment of tumour diseases. It stimulates the formative and integrative forces to dissolve and reintegrate growth processes that have become independent. It is used for the treatment of malignant and benign tumour diseases, for the prevention of tumour recurrence after operations and for defined preliminary stages of cancer. The dosage is individual and is started in an introductory phase with Iscador P Series 0. The optimal strength or dose must be determined individually and can be checked on the basis of patient reaction and tumour behaviour. The treatment is carried out for several years, during which breaks can be taken. There may be side effects such as local inflammatory reactions, mild swelling of regional lymph nodes and a temporary slight increase in body temperature. Iscador P is injected subcutaneously and should be stored in the refrigerator. The duration of application is determined by the doctor and depends on the risk of recurrence and the individual condition or findings of the patient. It is important to read the package leaflet thoroughly and to address any further questions to the doctor or pharmacist. Pharmaceutical entrepreneur and manufacturer: Weleda AG, Postfach 1320, D-73503 Schwäbisch Gmünd. This leaflet was last revised in June 2012. Source: Package leaflet (as of 10/2013).